European Journal of Molecular & Clinical Medicine

Abstract

COVID 19 being the deadliest disease all over the world regarded as the pandemic, the hope of every people is to get an effective medication that can counter it. There is a strong belief that chloroquine may help in controlling the virus. It is taken as an oral preparation. Chloroquine or hydroxychloroquine is a drug class 4- aminoquinoline. Chloroquine is contraindicated in people with heart disease or diabetes. It has a narrow therapeutic index and can cause toxicity easily.A derivative of chloroquine, hydroxychloroquine was synthesised first in 1946. Chloroquine is primarily used to prevent and treat malaria in areas where malaria remains sensitive to its effects. A self-administered questionnaire was prepared consisting of 10 questions and was distributed to a random population through Google docs and we got almost 100 responses. About 63% of the participants are aware of COVID-19 and chloroquine. SPSS software was used to analyse the data for descriptive statistics and chi-square analysis for association with gender. About 50% of the participants' perception is that chloroquine will protect them from COVID-19, and are aware that hydroxychloroquine and other forms of chloroquine are undergoing a clinical trial of COVID-19. If it succeeds it will have a big impact on the current crisis.